Cargando…
A novel viral vaccine platform based on engineered transfer RNA
In recent years, an increasing number of emerging and remerging virus outbreaks have occurred and the rapid development of vaccines against these viruses has been crucial. Controlling the replication of premature termination codon (PTC)-containing viruses is a promising approach to generate live but...
Autores principales: | Wang, Tong-Yun, Meng, Fan-Dan, Sang, Guo-Ju, Zhang, Hong-Liang, Tian, Zhi-Jun, Zheng, Hao, Cai, Xue-Hui, Tang, Yan-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769134/ https://www.ncbi.nlm.nih.gov/pubmed/36482724 http://dx.doi.org/10.1080/22221751.2022.2157339 |
Ejemplares similares
-
Engineered Viruses as Vaccine Platforms
por: Folgori, Antonella, et al.
Publicado: (2012) -
Genetically-engineered “all-in-one” vaccine platform for cancer immunotherapy
por: Wu, Aihua, et al.
Publicado: (2021) -
Green Tea Catechin-Inactivated Viral Vaccine Platform
por: Lee, Yun H., et al.
Publicado: (2017) -
Generation of Premature Termination Codon (PTC)-Harboring Pseudorabies Virus (PRV) via Genetic Code Expansion Technology
por: Wang, Tong-Yun, et al.
Publicado: (2022) -
The Nsp12-coding region of type 2 PRRSV is required for viral subgenomic mRNA synthesis
por: Wang, Tong-Yun, et al.
Publicado: (2019)